Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 890604

The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive


Juričić, Gordana; Saračević, Andrea; Milevoj Kopčinović, Lara; Bakliža, Ana; Šimundić, Ana- Maria
The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive // Clinical biochemistry, 49 (2016), 18; 1402-1405 doi:10.1016/j.clinbiochem.2016.03.006 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 890604 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive

Autori
Juričić, Gordana ; Saračević, Andrea ; Milevoj Kopčinović, Lara ; Bakliža, Ana ; Šimundić, Ana- Maria

Izvornik
Clinical biochemistry (0009-9120) 49 (2016), 18; 1402-1405

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Diabetes ; Glucomedics ; Glycolysis inhibitors ; Preanalytical phase ; Venosafe Glycemia

Sažetak
Citrate buffer additive has been suggested to be of supreme performance in inhibiting glycolysis. However, there is little evidence in the literature regarding the comparability of glucose concentrations in liquid and lyophilized citrate buffer containing tubes. The aim of this study was to compare glucose concentrations in tubes containing liquid (Glucomedics) and lyophilized citrate buffer (Terumo VENOSAFE™ Glycemia) additive, measured immediately after centrifugation.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti, Farmacija



POVEZANOST RADA


Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Klinička bolnica "Sveti Duh",
KBC "Sestre Milosrdnice",
Opća bolnica Pula,
Psihijatrijska bolnica "Sveti Ivan" Zagreb

Citiraj ovu publikaciju

Juričić, Gordana; Saračević, Andrea; Milevoj Kopčinović, Lara; Bakliža, Ana; Šimundić, Ana- Maria
The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive // Clinical biochemistry, 49 (2016), 18; 1402-1405 doi:10.1016/j.clinbiochem.2016.03.006 (međunarodna recenzija, članak, znanstveni)
Juričić, G., Saračević, A., Milevoj Kopčinović, L., Bakliža, A. & Šimundić, A. (2016) The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive. Clinical biochemistry, 49 (18), 1402-1405 doi:10.1016/j.clinbiochem.2016.03.006.
@article{article, year = {2016}, pages = {1402-1405}, DOI = {10.1016/j.clinbiochem.2016.03.006}, keywords = {Diabetes, Glucomedics, Glycolysis inhibitors, Preanalytical phase, Venosafe Glycemia}, journal = {Clinical biochemistry}, doi = {10.1016/j.clinbiochem.2016.03.006}, volume = {49}, number = {18}, issn = {0009-9120}, title = {The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive}, keyword = {Diabetes, Glucomedics, Glycolysis inhibitors, Preanalytical phase, Venosafe Glycemia} }
@article{article, year = {2016}, pages = {1402-1405}, DOI = {10.1016/j.clinbiochem.2016.03.006}, keywords = {Diabetes, Glucomedics, Glycolysis inhibitors, Preanalytical phase, Venosafe Glycemia}, journal = {Clinical biochemistry}, doi = {10.1016/j.clinbiochem.2016.03.006}, volume = {49}, number = {18}, issn = {0009-9120}, title = {The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive}, keyword = {Diabetes, Glucomedics, Glycolysis inhibitors, Preanalytical phase, Venosafe Glycemia} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font